Magnesium Sulfate Synchrony Pharma

Magnesium sulfate, the active ingredient in Magnesium Sulfate Synchrony Pharma, is an electrolyte supplement presented as an injectable solution for intravenous use. It is employed to prevent and treat eclampsia and severe preeclampsia, to correct magnesium deficiency, and to manage certain cardiac arrhythmias.

GNH USA supplies Magnesium Sulfate Synchrony Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for worldwide distribution to meet local regulatory requirements.

Magnesium sulfate is used in obstetric, cardiac and electrolyte disorders. - Eclampsia and severe preeclampsia: prevents seizures and reduces maternal hypertension. - Magnesium deficiency: restores normal serum magnesium concentrations. - Torsades de pointes: stabilises cardiac repolarisation and terminates ventricular tachycardia. - Severe asthma (adjunct): promotes bronchodilation and improves response to standard therapy.

Magnesium sulfate may cause a range of adverse reactions.

Common Side Effects: - Flushing or feeling of warmth. - Nausea or vomiting. - Headache. - Hypotension. - Muscle weakness or fatigue.

Serious or Rare Side Effects: - Respiratory depression or arrest. - Severe hypotension or cardiac arrest. - Hypermagnesemia with neuromuscular blockade. - Allergic reactions including anaphylaxis. - Tissue necrosis at the injection site.

Magnesium sulfate requires careful monitoring in several clinical situations. - Renal impairment: monitor serum magnesium and adjust dose. - Myasthenia gravis: may exacerbate muscle weakness. - Cardiac conduction disorders: use cautiously and observe ECG. - Pregnancy: category unknown; weigh maternal benefits against potential fetal risk. - Drug interactions: avoid concurrent calcium‑channel blockers or other magnesium‑containing products. - Store below 25°C: keep in original container, protect from light and moisture.

Magnesium sulfate can interact with several medicines, altering its safety profile.

Major Interactions (Avoid): - Calcium channel blockers: additive hypotensive effect. - Neuromuscular blocking agents: prolonged paralysis. - Other magnesium‑containing products: risk of hypermagnesemia.

Moderate Interactions (Monitor Closely): - Loop diuretics: increased renal magnesium loss. - Aminoglycosides: enhanced neuromuscular blockade. - β‑agonists: may reduce magnesium’s therapeutic efficacy.